Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Asdourian

Orthopaedic Surgery Baltimore, MD Medical Doctor

NPI 1962446765 CMS profile 315487

3333 North Calvert Street, Suite 400, Baltimore, MD 21218

Open in the dashboard

General payments

$44,966

78 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$529,942

7 holdings reported · through program year 2025

Through program year 2025, Paul Asdourian of Baltimore, MD is reported in the CMS Open Payments database as having received $44,966 across 78 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $529,942 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $987 9
2024 General $819 3
2023 General $2,412 15
2022 General $7,883 13
2021 General $6,265 9
2020 General $10,828 9
2019 General $15,772 20
2024 Ownership $291,275 2
2023 Ownership $223,000 1
2020 Ownership $7,834 2
2019 Ownership $7,834 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Asdourian
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Paul Asdourian were reported at $987. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Paul Asdourian Orthopaedic Surgery median Middle half National median
2019 $15,772 $644 $140–$2,844 $163
2020 $10,828 $312 $75–$1,860 $114
2021 $6,265 $520 $117–$2,495 $132
2022 $7,883 $598 $128–$2,731 $149
2023 $2,412 $461 $128–$2,264 $160
2024 $819 $497 $134–$2,475 $164
2025 $987 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alphatec Spine, Inc $31,123 23 payments
  2. Globus Medical, Inc. $12,456 41 payments
  3. Stryker Corporation $277 2 payments
  4. VB Spine LLC $276 1 payment
  5. Arthrex, Inc. $219 5 payments
  6. Circinus Medical Technology LLC $200 1 payment
  7. Supreme Orthopedic Systems, LLC $150 1 payment
  8. Medtronic, Inc. $147 1 payment
  9. KCI USA, Inc $103 2 payments
  10. Smith+Nephew, Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $36,102 35 payments
  2. Travel and Lodging $6,566 16 payments
  3. Food and Beverage $2,297 27 payments
Products named General payments · program years 2019–2025
  1. Novel $19,568 19 payments
  2. Novel SD $11,555 4 payments
  3. Novel LLC $11,555 4 payments
  4. INTERCONTINENTAL Spine $3,943 8 payments
  5. Joints $2,016 1 payment
  6. ExcelsiusGPS Robotic Navigation System $1,520 9 payments
  7. Excelsius Robotics System $1,219 3 payments
  8. INTERCONTINENTAL Spine/Joint $1,036 4 payments
  9. ALTERA $921 3 payments
  10. ELSA $864 3 payments
  11. Other $2,201 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

30

Median for Orthopedic Surgery: 203

Drug cost

$235

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 13 $150
Methylprednisolone Generic 17 $85

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$87,654

Medicare's payments for the services billed

Medicare patients

248

Average age 72

Services billed

712

140 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Ischemic heart disease 31%
Depression 27%
Chronic kidney disease 24%
Cancer 17%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

78 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record